EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 -1.053
March 31, 2026 -1.090
December 31, 2025 -1.148
September 30, 2025 -1.319
June 30, 2025 -1.453
March 31, 2025 -1.492
December 31, 2024 -1.650
September 30, 2024 -1.654
June 30, 2024 -1.708
March 31, 2024 -1.917
December 31, 2023 -1.634
September 30, 2023 -1.767
June 30, 2023 -2.170
March 31, 2023 -2.421
December 31, 2022 -2.910
September 30, 2022 -3.046
June 30, 2022 -2.639
March 31, 2022 -2.437
December 31, 2021 -2.237
September 30, 2021 -2.129
June 30, 2021 -2.350
March 31, 2021 -2.12
December 31, 2020 -2.079
September 30, 2020 -1.846
June 30, 2020 -1.568
Date Value
March 31, 2020 -1.574
December 31, 2019 -1.436
September 30, 2019 -1.310
June 30, 2019 -1.222
March 31, 2019 -1.232
December 31, 2018 -1.198
September 30, 2018 -1.240
June 30, 2018 -1.19
March 31, 2018 -1.05
December 31, 2017 -1.02
September 30, 2017 -0.94
June 30, 2017 -0.95
March 31, 2017 -1.01
December 31, 2016 -1.06
September 30, 2016 -1.11
June 30, 2016 -1.08
March 31, 2016 -1.12
December 31, 2015 -1.21
September 30, 2015 -1.25
June 30, 2015 -1.33
March 31, 2015 -1.30
December 31, 2014 -1.26
September 30, 2014 -1.25
June 30, 2014 -5.74
March 31, 2014 -5.729

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Agenus, Inc. 2.651
Amgen, Inc. 16.10
Anika Therapeutics, Inc. -0.2741
BioCryst Pharmaceuticals, Inc. -1.504
Imunon, Inc. -3.843